Table 1.

Baseline characteristics of patients

Patient	Age	Sex	Cause of ESRD	Use of other phosphorus binding agents	Adverse Events
1	74	F	Hypertension	Phoslo, renvela	gastrointestinal
2	49	F	Hypertension	Renagel	n/a
3	32	F	IgA nephropathy	Renvela	n/a
4	52	F	Lupus	n/a	musculoskeletal